The cellular prion protein (PrP^C^) is a ubiquitous glycosylphosphatidylinositol (GPI)-anchored cell surface N-linked glycoprotein \[[@r27]\]. The physiological roles of PrP^C^ remain elusive, but several reports have proposed some functions including anti-apoptosis \[[@r20]\], reduction of oxidative stress \[[@r19]\], cell adhesion \[[@r12]\] and copper cooperative neuroprotection \[[@r9]\]. Although the prion protein gene (*Prnp*) is predominately expressed in the central nervous system (CNS) by all known mammals, the pattern of gene activation is still poorly understood. The distribution of *Prnp* expression in various tissues has been analyzed in many mammals, including hamsters, sheep, mice and cattle \[[@r3], [@r7], [@r14], [@r29]\]. *Prnp* expression in the mouse brain is increased 4-fold in the period from birth to 3 weeks of age, and this higher level is maintained throughout adulthood \[[@r21], [@r22]\]. The mouse *Prnp* localized on chromosome 2 consists of three exons, with the third exon encoding the entire open reading frame \[[@r30]\]. In addition, the chromosome 2 including *Prnp* is closely linked to the incubation period of prion disease in mice \[[@r5], [@r6]\]. In mouse and rat *Prnp*, the region upstream of the first exon consists of high GC content including CCAAT box and three SP1 binding sites that have been shown to regulate the core promoter activity \[[@r2], [@r23]\]. However, there has been no epigenetic study including an investigation of DNA methylation on *Prnp*.

DNA methylation on the cytosine of CpG dinucleotides is an epigenetic modification that plays an important role in embryonic development, tumorigenesis, aging and other neurodegenerative disorders \[[@r1], [@r11], [@r13], [@r24]\]. A large number of vertebrate genes have been analyzed with respect to CpG frequency, the length of CpG islands (CGIs) and the presence of DNA methylation on housekeeping genes and tissue-specific genes \[[@r17]\]. In addition, CpG methylation is an epigenetic mark generally considered to induced transcriptional gene silence by inhibiting the association of DNA binding factors \[[@r4]\]. In order to address the effect of CpG methylation on *Prnp* expression, we investigated the correlation between the CpG methylation status and *Prnp* expression level in mouse tissues.

MATERIALS AND METHODS {#s1}
=====================

Mice
----

C57BL/6CrSlc and BALB/cCrSlc mice were purchased from Japan SLC. (Hamamatsu, Japan). Five male and five female mice aged 8 weeks were used in all experiments. The mouse studies were approved by the Ethical Committee for the Use of Experimental Animals of Kobe University (authorization number, 23-06-03). All efforts were made to minimize animal suffering and to reduce the number of animals. Each tissue was stored at −80°C until used.

DNA extraction and bisulfite sequencing PCR
-------------------------------------------

Genomic DNA samples were extracted from each mouse tissue using a PureLink Genomic DNA Kit (Thermo Fisher Scientific, Yokohama, Japan) according to the manufacturer's instructions. Genomic DNA samples were quantified and stored at −20°C until used. DNA samples (3 *µ*g) were then treated with bisulfite using a MethylEasy Xceed Rapid DNA Bisulfite Modification Kit (Takara, Otsu, Japan), and the bisulfite-treated DNA was used as a template for PCR. The PCR experiment was performed in a 50 *µl*reaction mixture containing 1.25 units of EpiTaq HS polymerase (Takara), 5 *µl* of 10 ×EpiTaq PCR Buffer, 2.5 mM MgCl~2~, 1.2 mM dNTP, 0.4 *µ*M of each primer and 50 *n*g of template DNA. The PCR primers for amplifying the bisulfite--converted mouse *Prnp* region were MePrP-1F (−682 to −661) (5′-GTGGGAGTTGTTAAATGTAGTG-3′), MePrP-1R (−154 to −175) (5′-CCCCAATATCAACACTCCCTAA-3′), MePrP-2F (−236 to −215) (5′-GGAGTATTGGGTATTGGATTAG-3′) and MePrP-2R (+347 to +325) (5′-CCAAAAACAATCAAAAAATACCA-3′) ([Fig. 1A](#fig_001){ref-type="fig"}Fig. 1.CpG dinucleotide positions on the mouse *Prnp* target gene and curve relationship between observed and expected methylation. (A) Positions of the CpG motif are indicated as open boxes and numbered from −1 to 46. Underlining and arrows denote the first exon and bisulfite PCR primer regions, respectively. Numbers on the right indicate nucleotide positions relative to the transcription initiation site of the *Prnp* gene. (B) Two approximate curves represent the relationships between observed and expected methylation status based on the results of resulting of multiple mixing experiments. Solid squares and triangles are plotted against the expected value using the forward and reverse sequencing primers, respectively. Each plot is shown as the average of twelve independent experiments.). PCR reactions were performed using the primer pair of MePrP-1F and MePrP-1R or MePrP-2F and MePrP-2R, followed by 40 cycles of 98°C for 10 sec, 60°C for 30 sec and 72°C for 30 sec. The PCR product was purified from 1.8% agarose gels using a Wizard^®^ SV Gel and PCR Clean-Up System Kit (Promega, Tokyo, Japan) and then subjected to direct sequencing.

The sequencing reaction (20*µl*) was carried out using 40 *n*g of template DNA, 4.5*µl* of BigDye Terminator v.3.1 Cycle Sequencing Kit (Thermo Fisher Scientific), 0.16 *µ*M primer (MePrP-1F, MePrP-1R, MePrP-2F or MePrP-2R) and the following protocol: 96°C for 1 min, followed by 25 cycles of 96°C for 10 sec, 50°C for 5 sec and 60°C for 4 min. The sequencing product was then run on an ABI prism 3130 Genetic Analyzer (Thermo Fisher Scientific). The percentage of methylation at each CpG site was calculated as the peak height of C divided the sum of the peak heights of C and T, 100 ×C/(C + T), as shown in the computer-generated raw sequencing chromatogram \[[@r16]\]. DNA methylation standards were prepared from cloned plasmid to mimic different methylation levels of CpG sites. To obtain the plasmid DNA standards, bisulfite-treated DNAs prepared from RAW264.7 cells were amplified by PCR using the primer pair of MePrP-1F and MePrP-1R, and cloned into the pMD20 plasmid. After sequencing analysis, two of these clones were derived from completely methylated and unmethylated for the CpG sites. Two plasmids were mixed and sequenced to mimic different DNA methylation percentages: 0, 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100%.

RNA extraction and real-time quantitative RT-PCR
------------------------------------------------

Total RNA was isolated from each type of tissue using an RNeasy Plus Mini Kit (Qiagen, Tokyo, Japan) and was stored at −80°C until used.

Real-time quantitative RT-PCR (qRT-PCR) was performed with a Thermal Cycler Dice Real Time System TP800 (Takara) using One Step SYBR^®^ PrimeScrip PLUS RT-PCR kit (Takara). The primer pairs for qRT-PCR were 5′-TCCAATTTAGGAGAGCCAAGC-3′ and 5′-GCCGACATCAGTCCACATAG-3′ for mouse *Prnp* mRNA and 5′-AGCCAAGCACATACACCAAA-3′ and 5′-GGGTTTAGACCGTCGTGAGA-3′ for 28S rRNA, respectively. The PCR amplification was carried out in a 25 *µl* reaction mixture containing 5 *n*g (for 28S rRNA) or 50 *n*g (for *Prnp*) of total RNA, 0.4 *µ*M of each primer, 12.5 *µl* of 2 ×One Step RT-PCR Buffer 4, 1.5 *µl* of TaKaRa Ex Taq HS Mix and 0.5 *µl* of PrimeScript PLUS RTase Mix. The PCR conditions consisted of an initial reverse transcription step for 5 min at 42°C and a polymerase activation step for 10 sec at 95°C, followed by 45 cycles of 95°C for 5 sec and 65°C for 30 sec. Both dissociation curve analysis and agarose gel electrophoresis were used to check the specificity of the qRT-PCR.

Statistical analysis
--------------------

Statistical analysis was performed using Student's *t*-test. Significance was defined as *P*\<0.01. Pearson's correlation analysis was performed to investigate the relationship between DNA methylation levels of CpG sites and mRNA expression of *Prnp*. A *P*-value \<0.05 was considered statistically significant.

RESULTS {#s2}
=======

CpG site methylation status of the Prnp promoter region in mouse tissues
------------------------------------------------------------------------

To investigate sense-strand CpG site methylation in *Prnp*, we performed bisulfite sequencing PCR amplification of regions (−682 to −154 and −236 to +347) using two pairs of primers ([Fig. 1A](#fig_001){ref-type="fig"}). This region contained a total of forty-six CpG dinucleotides numbered from CpG 1 to CpG 46. The sequence search revealed that the CGI spanned between nucleotides −218 and +152 (370 bp), a region containing thirty-two CpG sites (CpGs 9 to 40 and −180 to +142) and the entire length of the first exon (+1 to +67). No other CGIs were present in \~5 kb of either the upstream or downstream regions around the first exon.

To verify and calibrate the status of every CpG, we prepared and sequenced two reference plasmids containing the complete methylated or non-methylated gene at CpGs 1 to 4 (positions −599, −576, −336 and −326) ([Fig. 1B](#fig_001){ref-type="fig"}). The percentage of observed methylation at every CpG site was calibrated to the expected methylation rate by the equations described in [Fig. 1B](#fig_001){ref-type="fig"}. The methylation analysis of the forty-six CpG sites (−599 to +286) in thirty-four C57BL/6 mouse tissues showed that CpGs 8 to 46 (−238 to +286) containing the CGI (CpGs 9 to 40) were completely unmethylated in all tissue samples, whereas CpGs 1 to 7 exhibited various methylation statuses in a tissue-specific manner ([Fig. 2A and 2B](#fig_002){ref-type="fig"}Fig. 2.CpG site- and tissue-specific methylation status in mice. Pie charts representing the percentage methylation at each CpG position are shown. The methylation ratio is shown as a black region representing the average of six analyzed values from each of two males (A) and females (B). Pie charts of CpG sites 9 to 45 are not included, because these sites were unmethylated.). The complete absence of CGI methylation in all tissues indicated that *Prnp* was a typical house-keeping gene. In addition, the methylation statuses of the respective forty-six CpGs were shown to be not significantly different between male and female mouse tissues (*P*\>0.01). The partial methylation of CpGs 1 to 4 among mouse tissues ranged from \~23% to 89% (average 53%), \~5% to 47% (average 17%), 0% to 34% (average 14%) and 0% to 27% (average 11%), respectively. Only in testis, CpGs 3 and 4 were completely unmethylated. At CpGs 5 to 7, very low levels of methylation were found in the stomach, kidney, adrenal gland, eyeball and blood. In the cerebrum and liver only, we also investigated the CpG methylation of an additional upstream region (−1,379 to −758) in *Prnp*. This fragment contained six CpG sites (−1,275, −1,273, −1,271, −1,182 and −864) that showed 100% methylations.

Correlation between the CpG site methylation and Prnp expression
----------------------------------------------------------------

To evaluate the degree of correlation between the CpG site methylation and *Prnp* transcripts, we also performed quantitative real-time RT-PCR (qRT-PCR) analysis of *Prnp* in thirty-four individual tissue samples from C57BL/6 mice ([Fig. 3A](#fig_003){ref-type="fig"}Fig. 3.Mouse *Prnp* gene expression in each type of mouse tissue and comparison of DNA methylation between C57BL/6 and BALB/c mice. (A) The *Prnp* mRNA level in the cerebrum is presented as 100. Data are presented as the means ± SD and obtained from three independent experiments from male mice, except for the ovary and uterus. Comparison of the methylation levels at CpG positions 1 (B), 2 (C), 3 (D) and 4 (E) in C57BL/6 (solid bars) and BALB/c (open bars) mice. \**P*\<0.01, Student's *t*-test. (F) Comparison of *Prnp* gene expression in C57BL/6 (solid bars) and BALB/c (open bars) mice. All data are presented as the means ± SD.). To assess the expression levels of *Prnp*, the 28S rRNA mRNA was chosen as the reference transcript, because it is conveniently assayed. To avoid spurious PCR amplification from mouse genomic DNA, we designed the PCR forward and reverse primers located in the first exon and second exon for *Prnp*, and fifth exon and sixth exon for 28S rRNA, respectively. *Prnp* transcripts were readily detected in all samples and varied considerably among the different tissues. The highest amount of *Prnp* mRNA was found in the cerebrum (100), followed by the cerebellum (79.5 ± 17.7), diencephalon (68.3 ± 19.4), olfactory bulb (50.4 ± 19.8), medulla oblongata (49.0 ± 9.8), thalamus (35.8 ± 8.3), spinal cord (29.6 ± 9.8) and pituitary gland (22.7 ± 5.2). The lowest level of *Prnp* transcripts was detected in the pancreas (0.10 ± 0.003), followed by the blood (0.14 ± 0.04), duodenum (0.5 ± 0.1), jejunum (0.7 ± 0.2) and gallbladder (0.9 ± 0.2). In other tissues, *Prnp* expression levels ranged from 1.3% to 19.6% that in the cerebrum.

Based on the qRT-PCR results and the calculated methylation percentages for individual CpG sites, we performed a correlation analysis ([Table 1](#tbl_001){ref-type="table"}Table 1.Correlation analysis between methylation and expression of *Prnp*CpG 1***CpG 2***CpG 3CpG 4CpG 5CpG 6CpG 7Pearson's (*r*-values)0.064***--0.374***--0.264--0.285--0.142--0.142--0.114*P*-value0.730***0.035***0.1450.1150.4370.4370.535Pearson's *r*-values ≥ ± 0.3 and *P*-values ≤0.05 are considered to indicate significant correlations. CpG 2, where methylation is negatively correlated with *Prnp* expression, is shown in bold and italic.). The results revealed a significant negative correlation between CpG site methylation at position 2 (−576) and *Prnp* mRNA expression (Pearson's *r*= −0.374, *P*=0.035), but no significant correlations were observed between methylation and *Prnp* mRNA level at CpG 1 or CpGs 3--7 (*P*\>0.05). The location of CpG 2 was composed of the sequence CACGAG termed the N-box which bound predictively with the basic helix-loop-helix (bHLH) family of transcription factors \[[@r15]\]. No other CpG positions (CpG 1 and CpGs 3--46) were present in the N-box regulatory elements ([Fig. 1A](#fig_001){ref-type="fig"}). In addition, the sequences CACGAG did not exist within 5 kb of the first exon of *Prnp* in either direction. Moreover, the sequence GAGGG (position between −569 and −565) with an oppositely oriented CCCTC motif was located in close proximity to CpG 2 (−576), which was predicted to bind with the CCCTC-binding factor (CTCF) involved in insulator activity \[[@r8]\]. The CTCF binding motif was also found at the *Prnp* core promoter region (position between −40 and −36).

Differential Prnp methylation in the testis between C57BL/6 and BALB/c
----------------------------------------------------------------------

To further characterize *Prnp* CpG methylation and expression in the testis, we also performed bisulfite sequencing PCR and qRT-PCR in several BALB/c mouse tissues. Methylation analysis of a total of forty-six CpG sites in the BALB/c cerebrum, cerebellum and testis revealed that CpGs 5 to 46 were also completely unmethylated like those of C57BL/6 mice. Statistical analysis showed that the methylation statuses of CpGs 1 to 4 in both the cerebrum and cerebellum were not significantly different between C57BL/6 and BALB/c mice ([Fig. 3B--3E](#fig_003){ref-type="fig"}). On the other hand, the methylation ratios of *Prnp* in the BALB/c testis were calculated as 42.8 ± 1.1% for CpG 1, 18.4 ± 2.5% for CpG 2, 4.2 ± 0.9% for CpG 3 and 4.1 ± 2.0% for CpG 4. We found that DNA in the BALB/c mouse testis was significantly more methylated in CpGs 1 (*P*=0.0008), 3 (*P*=5.0 × 10^−7^) and 4 (*P*=0.0005) than that in the C57BL/6 mouse testis, whereas the CpG 2 site showed similar methylation percentages between the two mouse lines (*P*=0.727). In the cerebrum, cerebellum and testis, qRT-PCR analysis of *Prnp* mRNA levels showed no significant differences between C57BL/6 and BALB/c mice ([Fig. 3F](#fig_003){ref-type="fig"}). These results suggested that the differential methylation statuses of CpGs 1, 3 and 4 had no discernible impact on *Prnp* expression in the testis between C57BL/6 and BALB/c. These investigations together with the correlation results suggested that no significant difference of methylation at CpG 2 site between the two mouse lines might lead to the same extent of *Prnp* expression in testes.

DISCUSSION {#s3}
==========

This study is the first report to describe an association between the DNA methylation on CpGs and *Prnp* gene expression. The CGIs located at the gene promoter region in housekeeping genes are constitutively unmethylated, whereas the tissue-specific genes are methylated in most cells \[[@r17]\]. In the present study, *Prnp* was confirmed to be a typical housekeeping gene by demonstrating the absence of CpG methylation in the entire CGI (CpGs 9 to 40), including the core promoter region (CpGs 20 to 24) ([Fig. 2](#fig_002){ref-type="fig"}).

In general, enhancer regions tend to have mostly CpG-poor and variable methylation conditions termed low-methylated regions (LMRs) \[[@r26]\]. Our results suggested that one of the *Prnp* enhancer regions was localized at −599 to −279 (CpGs 1 to 7) with varying methylation status among tissues. In fact, CpG 2 (−576) was located in a CpG-poor region in a differentially methylated region, and its methylation status was negatively correlated with *Prnp* expression ([Table 1](#tbl_001){ref-type="table"}). Interestingly, only the CpG 2 site between CpG 1 and CpG 46 was located above the sequence CACGAG, which is termed the N-box and binds to members of the bHLH family of transcription repressors, such as HES-1 (mouse homologue of *Drosophila hairy* and *Enhancer* of *split* 1 protein) \[[@r15]\]. While the negative correlation between CpG 2 methylation at a repressor element and *Prnp* expression is difficult to explain, it may suggest that *Prnp* transcriptional regulation is associated in some way with HES-1. HES-1 influences the maintenance of neural stem and progenitor cells and thereby plays a major role in CNS development \[[@r18]\]. The *Hes1*mRNA is present at a high level in the mouse embryonal neuroepithelium proliferating neural precursor cells, whereas its expression is very low in the adult CNS \[[@r25]\].

On the one hand, *Prnp* mRNA in mouse embryos is detected in the CNS and peripheral nervous system where is localized with differentiated neuronal cells. In addition, *Prnp* expression is dramatically increased after birth until 3 weeks of age and then maintained at a consistent level throughout adulthood \[[@r21], [@r22]\]. As seen above, the regulation of *Prnp* expression follows quite a different pattern than that of *Hes1* expression during the fetal and adult stages in the nervous system. Our finding that CpG 2 methylation is negatively correlated with *Prnp* expression, suggests that an unknown enhancer factor might bind to the N-box and shelter it from the effects of transcriptional repressors, such as HES proteins, in order to promote high level *Prnp* expression in the CNS.

In N2a mouse neuroblastoma cells, artificially overproduced HES-1 has been shown to dramatically reduce the expression of *Prnp* \[[@r31]\]. Our sequence data for N2a cells showed that *Prnp* was identical to that of [Fig. 1.](#fig_001){ref-type="fig"} Moreover, the promoter analysis for I/LnJ mouse *Prnp* showed that the deletion from −663 to −537 resulted in about 1.5-fold increase in activity \[[@r2]\]. However, the *Prnp* fragment derived from I/LnJ mouse has a base substitution from "CG" to "GG" at CpG 2 (−576) position, resulting in the destruction of N-box consensus sequence \[[@r15]\]. Further researches are needed to be confirmed whether this single-nucleotide polymorphism affects *Prnp* expression at various steps in mouse. Interestingly, a recent report suggests that HES-1 is switched from a transcriptional repressor to a transcriptional activator to induce the expression of cartilage catabolic factor genes including *Adamts5*, *Mmp13*, *Il6* and *Il1rl1* \[[@r28]\]. Our observations imply that an expected protein binding to the *Prnp* N-box might act as a transcriptional enhancer but not a repressor in the adult mouse stage.

We also found that a motif (position −569 to −565) for the CTCF termed the insulator element was situated close to the CpG 2 site (position −576). The CCCTC insulator has been well-described as an element that interferes with the interaction between an enhancer (or a repressor) and a promoter \[[@r10]\]. CTCF also participates in chromatin organization and remodeling, contributing to the repression or activation of gene transcription \[[@r8]\]. Although it is necessary to determine what kind of transcriptional factors would bind to the sequence CACGAGATTGAGGG and its reverse complement CCCTCAATCTCGTG, the CpG 2 site methylation might play an important role in the regulation of *Prnp* gene expression.

In conclusion, we have demonstrated that the CGI of *Prnp* is completely unmethylated and that CpG methylation at nucleotide position −576 (CpG 2) appears to act as an important regulator of *Prnp* expression. Although comparable phenomena have remained unclear in the human and bovine PrP gene (*PRNP*), the C57BL/6 strain is of particular importance as a prion infection model in addition to a source of transgenic and knockout mice. Therefore, our findings provide novel information on the epigenetics of the *Prnp* gene and could ultimately contribute to elucidation of the molecular pathogenesis of prion diseases and the development of effective treatments.
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